Cite
MLA Citation
Ingrid Vandenput et al.. “Expression of ERCC1, p53, and Class III β-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer: Results From an Immunohistochemical Study.” International journal of gynecological cancer, vol. 21, no. 6, 2011, pp. 1071–1077. http://access.bl.uk/ark:/81055/vdc_100135138589.0x000019